References: 1. Breo Ellipta Data Sheet, GSK New Zealand, available at www.medsafe.govt.nz2. Breo Ellipta Consumer Medical Information, GSK New Zealand, available at www.medsafe.govt.nz3. Bernstein DI, et al. J Asthma 2015;52:1073-1083 4. Anoro Ellipta Data Sheet, GSK New Zealand, available at www.medsafe.govt.nz5. Anoro Ellipta Consumer Medical Information, GSK New Zealand, available at www.medsafe.govt.nz6. Maleki-Yazdi MR, Adv Ther; 2016;33;2188-2199. 7. Feldman GJ et al. Adv Ther 2017;34;2518–2533. 8. Maltais F et al. Adv Ther 2019;36:2434-2449.
Anoro Ellipta (umeclidinium bromide/vilanterol trifenatate inhaler 62.5/25mcg per inhalation) is a Prescription Medicine. Anoro Ellipta is used for long-term regular treatment to relieve symptoms in adults with Chronic Obstructive Pulmonary Disease (COPD). Anoro Ellipta is a fully funded medicine. Use strictly as directed. Do not take Anoro Ellipta to treat asthma or to relieve acute symptoms. Always carry your reliever inhaler. This medicine has risks and benifits. Tell your doctor: If you have severe milk-protein allergy, or you have demonstrated hypersensitivity to either umeclidinium, vilanterol trifenatate or any of the excipients in Anoro Ellipta, or if you are taking other medicines or herbal remedies, you have heart problems or high blood pressure, liver or thyroid problems, epilepsy or other seizure disorders, difficulty passing urine, a blockage in your bladder or other bladder problems, chronic or untreated infection, narrow-angle glaucoma or diabetes. Side Effects: Sore throat with or without a runny nose, cough, constipation, dry mouth, painful and frequent urination, pain and irritation in the back of the mouth and throat, infection of the upper airways, pain of the sinuses.
If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information see Anoro Ellipta Consumer Medicine Information at www.medsafe.govt.nz. Normal doctor's charges apply. Ask your doctor if Anoro Ellipta is right for you.
Breo Ellipta (fluticasone furoate/vilanterol trifenatate inhaler 100/25mcg per inhalation) is a Prescription Medicine.Breo Ellipta is used for the regular treatment of asthma (12 years of age and older) and for adults with Chronic Obstructive Pulmonary Disease (COPD). Breo Ellipta 100/25mcg is a fully funded medicine; Breo Ellipta 200/25mcg is a private purchase medicine (dose indicated in asthma only). Use strictly as directed. Breo Ellipta is not for relief of acute symptoms; a separate reliever inhaler may be required. Always carry your reliever inhaler. Do not discontinue Breo Ellipta abruptly. This medicine has risks and benefits. Tell your doctor: If you are taking any other medicines or herbal remedies, you have liver disease, heart problems, high blood pressure, pulmonary tuberculosis (TB), infection of the lungs (pneumonia) or weak bones (oesteoporosis). Side Effects: Headache, common cold, oral thrush, infection of the nose sinuses or throat, flu (influenza), pain and irritation at the back of the mouth and throat, inflammation of the sinuses, pneumonia (in patients with COPD) and weakening of the bones, leading to fractures. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information see Breo Ellipta Consumer Medicine Information at www.medsafe.govt.nz. Normal doctor's charges apply. Ask your doctor if Breo Ellipta is right for you.
